(Q44238813)

1 December 2017

title

The prevalence of human parvovirus B19 DNA and antibodies in blood donors from four Chinese blood centers (English)

1 reference

1 December 2017

1 reference

Ling Ke

1

1 reference

1 December 2017

Miao He

2

1 reference

1 December 2017

Changqing Li

3

1 reference

1 December 2017

Yu Liu

4

1 reference

1 December 2017

Lei Gao

5

1 reference

1 December 2017

Fuzhu Yao

6

1 reference

1 December 2017

Julin Li

7

1 reference

1 December 2017

Xinhong Bi

8

1 reference

1 December 2017

Yunlai Lv

9

1 reference

1 December 2017

Jingxing Wang

10

1 reference

1 December 2017

Matthew L Hirsch

11

1 reference

1 December 2017

Wuping Li

12

1 reference

1 December 2017

publication date

7 March 2011

1 reference

1 December 2017

1 reference

1 December 2017

volume

51

1 reference

1 December 2017

issue

9

1 reference

1 December 2017

page(s)

1909-1918

1 reference

Evolutionary relationships among parvoviruses: virus-host coevolution among autonomous primate parvoviruses and links between adeno-associated and avian parvoviruses

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03067.X

21 January 2018

Human parvovirus B19.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03067.X

Genetic diversity within human erythroviruses: identification of three genotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03067.X

Parvovirus-like particles in human sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03067.X

Cloning of a human parvovirus by molecular screening of respiratory tract samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03067.X

Identification and characterization of persistent human erythrovirus infection in blood donor samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03067.X

Rapid sequence change and geographical spread of human parvovirus B19: comparison of B19 virus evolution in acute and persistent infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03067.X

The age-specific prevalence of human parvovirus immunity in Victoria, Australia compared with other parts of the world

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03067.X

Human parvovirus B19 infection in blood donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03067.X

Parvovirus B19 infection-related complications in renal transplant recipients: treatment with intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03067.X

Persistent parvovirus B19 infection without the development of chronic anemia in HIV-infected and -uninfected children: the Women and Infants Transmission Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03067.X

Persistent B19 infection in immunocompetent individuals: implications for transfusion safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03067.X

Human erythrovirus B19 and blood transfusion - an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03067.X

Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03067.X

The transfusion-associated transmission of parvovirus B19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03067.X

Large-scale screening for human parvovirus B19 DNA by PCR: application to the quality control of plasma for fractionation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03067.X

Evaluation of different assays for the detection of parvovirus B19 DNA in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03067.X

Collaborative study to establish a replacement World Health Organization International Standard for parvovirus B19 DNA nucleic acid amplification technology (NAT)-based assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03067.X

Analysis of nucleotide sequences of human parvovirus B19 genome reveals two different modes of evolution, a gradual alteration and a sudden replacement: a retrospective study in Sapporo, Japan, from 1980 to 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03067.X

The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03067.X

MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) Software Version 4.0

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03067.X

A multi-Chinese blood center study testing serologic-negative donor samples for hepatitis C virus and human immunodeficiency virus with nucleic acid testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03067.X

Phylogenetic analysis of human parvovirus B19, indicating two subgroups of genotype 1 in Vietnamese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03067.X

Identification and characterization of a second novel human erythrovirus variant, A6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03067.X

A new parvovirus genotype persistent in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03067.X

Detection of parvovirus B19 IgG: choice of antigens and serological tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03067.X

Immune response to B19 parvovirus and an antibody defect in persistent viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03067.X

Effects of transfusion on human erythrovirus B19-susceptible or -infected pediatric recipients in a genotype 3-endemic area

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03067.X

Reactivity of genotype-specific recombinant proteins of human erythrovirus B19 with plasmas from areas where genotype 1 or 3 is endemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03067.X

Seroprevalence of parvovirus B19 in the German population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03067.X

The burden of parvovirus B19 infection in women of childbearing age in England and Wales

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03067.X

Seroprevalence of IgG against conformational and linear capsid antigens of parvovirus B19 in Italian blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03067.X

10.1111/J.1537-2995.2011.03067.X

21 January 2018

Identifiers

DOI

1 reference

1 December 2017

1 reference